Xeris Pharmaceuticals Files to Raise $75 Million in an IPO
SiliconHills
MAY 25, 2018
Xeris Pharmaceuticals, founded in 2005 in Austin, filed on Thursday with the Securities and Exchange Commission to go public on the Nasdaq Stock Exchange with an initial public offering valued at $75 million. The company, now based in Chicago, has strong ties to the Austin startup community.
Let's personalize your content